Skip to main content
Premium Trial:

Request an Annual Quote

Just Ask For It

Diane Shao, now a medical resident and postdoctoral researcher at Boston Children's Hospital, writes at Science that she got her first research job at age 15 by emailing scientists and then showing up at their offices.

She took a similar go-getter approach in college when she asked potential advisers whether they thought they had a low-risk project she could take on and get a first-author paper out of. While she says that some professors didn't care for her approach, she found a researcher who had just the project for her, and she was his only undergrad to graduate with a first-author paper.

Shao notes in her piece at Science that "people who actively promote themselves or advocate for their careers" are thought to be by many in academia "less intelligent or less deserving" as talent is often thought to be the key to a successful career.

But that isn't quite true, according to Shao. "The reality is that creating opportunities for career advancement is as important as innate scientific talent," she says.

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.